Literature DB >> 2326728

Effect of early operation on cerebral vasospasm.

T Inagawa1.   

Abstract

The effect of early operation on cerebral vasospasm was studied in 150 patients with aneurysmal subarachnoid hemorrhages who fulfilled all of the following criteria: admission by day 2 after subarachnoid hemorrhage, no rebleeding, clinical grades I to IV on admission, subarachnoid hemorrhage alone on computed tomography scan, not operated on between days 4 and 20, and availability of bilateral carotid angiograms done by day 2 and redone between days 7 and 9. The patients were divided into two groups: those operated on by day 3 (group 1: 116 patients) and those operated on after day 20 or not operated on (group 2: 34 patients). Severity of both subarachnoid hemorrhage on computed tomography scan and angiographic vasospasm were graded into 0-IV. Angiographic vasospasm was observed in 95% of group 1 and in 88% of group 2 patients. A significant difference could not be found between groups 1 and 2 in the angiographic vasospasm grades. The incidence of symptomatic vasospasm in group 1 was 18%, which was significantly lower than the 44% in group 2. In group 1 patients with subarachnoid hemorrhage grades II to III, the incidences of symptomatic vasospasm and low density area on computed tomography scan were 13% and 10%, respectively. Both of these rates were significantly lower than those in group 2, which were 50% and 36%, respectively. However, in patients with subarachnoid hemorrhage grade IV, no differences could be found between groups 1 and 2. There was a close correlation between the angiographic vasospasm grades and the incidence of symptomatic vasospasm in group 1. However, in group 1, no correlation could be observed between the site of ruptured aneurysms or the timing of operations and vasospasm. Although there is still a limit to the effect of early operation on cerebral vasospasm in patients with subarachnoid hemorrhage grade IV, symptomatic vasospasm after subarachnoid hemorrhage may be ameliorated by early operation in patients with subarachnoid hemorrhage grades II to III.

Entities:  

Mesh:

Year:  1990        PMID: 2326728     DOI: 10.1016/0090-3019(90)90042-n

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

1.  MR imaging after aneurysmal subarachnoid hemorrhage and surgery: a long-term follow-up study.

Authors:  R P Kivisaari; O Salonen; A Servo; T Autti; J Hernesniemi; J Ohman
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

2.  Surgical treatment of multiple intracranial aneurysms.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Experimental basilar artery spasm caused by autologous blood application: effects of clot removal and topical nicardipine.

Authors:  R Tuncer
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

4.  Effect of ultra-early referral on management outcome in subarachnoid haemorrhage.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

5.  Cerebral vasospasm in elderly patients treated by early operation for ruptured intracranial aneurysms.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

6.  Effect of continuous cisternal drainage on cerebral vasospasm.

Authors:  T Inagawa; K Kamiya; Y Matsuda
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

7.  Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Authors:  Tetsuji Inagawa; Kaita Yahara; Naohiko Ohbayashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-03-27       Impact factor: 1.742

8.  Staged treatment for ruptured wide-neck intracranial aneurysm with intentional partial coiling in the acute phase followed by definitive treatment.

Authors:  Hiroki Yamazaki; Toshiyuki Fujinaka; Tomohiko Ozaki; Tomoki Kidani; Keisuke Nishimoto; Kowashi Taki; Naoki Nishizawa; Keijiro Murakami; Yonehiro Kanemura; Shin Nakajima
Journal:  Surg Neurol Int       Date:  2022-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.